Most Recent Articles about TEVA
Teva Vs. Amneal: JPMorgan Sees Hope For One, Decline For The Other Nov 12, 2019 -

It’s been a rough 2019 for some biotechs. Amneal Pharmaceuticals Inc (NYSE: AMRX) is down 81% year-to-date, while Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is down 41%.

Is Teva Pharmaceutical Industries Ltd. (TEVA) a Great Value Stock Right Now?|yseop_template_2-614175 Nov 11, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Teva launches $1.5B debt offering Nov 08, 2019 - Aimed at rolling over three series of outstanding debt due in 2021, Teva Pharmaceutical Industries (TEVA +4.5%) launches a $1.5B private offering Euro-denominated Senior Notes.Pricing and terms have y

Related Companies

Name Exchange Price Mkt Cap
ALXN Alexion Pharmaceuticals, Inc. NASDAQ $117.77 $26.25B
MYL Mylan N.V. NASDAQ $37.22 $19.19B
BMRN BioMarin Pharmaceutical Inc. NASDAQ $98.11 $17.42B
GRFS Grifols, S.A. NASDAQ $20.42 $13.96B
SRPT Sarepta Therapeutics, Inc. NASDAQ $152.52 $10.13B
Sector: Health Care > Industry: Major Pharmaceuticals